A research study demonstrated that viloxazine (Qelbree) significantly reduced executive function deficits in children, though the caveat is that these results may not always generalize to adults; however, the pharmacological profile suggesting improvement in executive dysfunction is promising enough to warrant clinical trials in adults.
factualpending
Speaker
Dr. Tracey MarksEvidence Quote
“Qelbree significantly reduced executive function deficits”
Created: 8/11/2026, 5:26:50 AM
Your notes
Loading notes...